| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |